TNFRSF1B Is Associated with ANCA in IBD

Area of Science:

• Genetics
• Immunology
• Gastroenterology

Background:

• Antineutrophil cytoplasmic antibodies (ANCA) are key biomarkers for inflammatory bowel disease (IBD).
• Previous genome-wide investigations into the genetic underpinnings of ANCA in IBD are limited.

Purpose of the Study:

• To conduct a comprehensive genome-wide association study (GWAS) to identify genetic variants associated with ANCA levels in IBD patients.
• To explore the functional implications of identified genetic variants on ANCA levels and serum tumor necrosis factor receptor 2 (TNFR2) levels.

Main Methods:

• A two-stage genome-wide association study (GWAS) was performed on 2959 IBD cases for discovery, followed by replication in 419 IBD cases.
• Statistical analyses included association testing, meta-analysis, and examination of the association between the identified variant and serum TNFR2 levels.

Main Results:

• A significant association was found between a variant in the TNFRSF1B gene (rs5745994) and ANCA levels in IBD patients (P = 8.97 × 10^-10).
• This association was consistently replicated across discovery and independent cohorts.
• The identified TNFRSF1B variant showed a statistically significant negative association with serum TNFR2 levels (P = 0.033).

Conclusions:

• The study identified a novel genetic variant in TNFRSF1B associated with ANCA levels in IBD, suggesting a role in IBD serology.
• The findings indicate a functional link between the TNFRSF1B variant and TNFR2 levels, potentially influencing IBD pathogenesis and treatment response.